Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Omeros Corp.
Pharmaceutical Preparations WA, United States
Nasdaq: OMER
Company Description
Omeros Corp. is a clinical stage biopharmaceutical company engages in discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The company's products are derived from its proprietary PharmacoSurgery platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. It also has a deep and diverse pipeline of preclinical programs as well as a platform capable of unlocking new drug targets. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
Similar to: NPS Pharmaceuticals, Inc., BioGaia AB, Sareum Holdings Plc
Featured Company
Fidelity China Special Situations Plc
Surrey, SU, GB
Fidelity China Special Situations Plc is an investment trust with the interest in investments in equities, index linked, equity linked,… Learn more →
Social Monitor
You may also be interested in:
Sareum Holdings Plc
Cambridge, EA, GB
Sareum is a drug discovery company, headquartered in Cambridge UK, that produces targeted small molecule therapeutics, focusing on… Learn more →
BioGaia AB
Stockholm, SE
BioGaia develops, markets and sells probiotic products with documented health benefits. Its products are primarily based on different… Learn more →
NPS Pharmaceuticals, Inc.
Bedminster, NJ, US
NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs… Learn more →